Cargando…

CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma

BACKGROUND: Renal cell carcinoma (RCC) is characterized by significant vascularization and immunogenicity, which contributes to drug resistance and immune escape. CD248, a pericytes marker in tumor vasculature, might help explain tumor microenvironment (TME) remodeling and serve as a novel therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shaojie, Xu, Chao, Zhang, Keying, Han, Donghui, Yang, Fa, Li, Yu, Zhao, Xiaolong, Ma, Shanjin, Li, Hongji, Lu, Shiqi, Lu, Tong, Zhang, Jiayu, Qin, Weijun, Wen, Weihong, Yang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743697/ https://www.ncbi.nlm.nih.gov/pubmed/35071435 http://dx.doi.org/10.21037/atm-21-6271

Ejemplares similares

CD248(+) Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma
por: Xu, Chao, et al.
Publicado: (2021)

The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021)

CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation
por: Lu, Shiqi, et al.
Publicado: (2023)

Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts
por: Liu, Shaojie, et al.
Publicado: (2022)

Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021)

Prognostic value and underlying mechanism of autophagy-related genes in bladder cancer
por: Peng, Shiyuan, et al.
Publicado: (2022)

Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues
por: Zhang, Jiayu, et al.
Publicado: (2022)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
por: Gan, Kai, et al.
Publicado: (2022)

Single-cell analysis reveals the COL11A1(+) fibroblasts are cancer-specific fibroblasts that promote tumor progression
por: Zhang, Jiayu, et al.
Publicado: (2023)

Correction to: Endosialin‑positive tumor‑derived pericytes promote tumor progression through impeding the infiltration of CD8(+) T cells in clear cell renal cell carcinoma
por: Lu, Tong, et al.
Publicado: (2023)

Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8(+) T cells in clear cell renal cell carcinoma
por: Lu, Tong, et al.
Publicado: (2023)

An enhancer RNA-based risk model for prediction of bladder cancer prognosis
por: Xu, Zhicheng, et al.
Publicado: (2022)

The higher levels of self-reported satisfaction, the lower risk of depressive symptoms: Evidence from a nationwide cross-sectional study in China
por: Niu, Zhiping, et al.
Publicado: (2022)

Cd248a and Cd248b in zebrafish participate in innate immune responses
por: Li, Xianpeng, et al.
Publicado: (2022)

Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Jiao, Jianhua, et al.
Publicado: (2022)

A Differential Role for CD248 (Endosialin) in PDGF-Mediated Skeletal Muscle Angiogenesis
por: Naylor, Amy J., et al.
Publicado: (2014)

Prospect of Prostate Cancer Treatment: Armed CAR-T or Combination Therapy
por: Jiang, Yao, et al.
Publicado: (2022)

Health Tract, No. 248: Weights and Measures
Publicado: (1866)

Genetic testing of 248 Chinese aortopathy patients using a panel assay
por: Yang, Hang, et al.
Publicado: (2016)

P248 Fungal meningitis in an immunocompetent individual
por: Ningthoujam, Priyolakshmi, et al.
Publicado: (2022)

Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade
por: Zheng, Weiwei, et al.
Publicado: (2022)

Correction to Lancet Oncol 2016; 17: 248, 252
Publicado: (2016)

Sulfonated Compounds Bind with Prostatic Acid Phosphatase (PAP(248–286)) to Inhibit the Formation of Amyloid Fibrils
por: Zhang, Tingting, et al.
Publicado: (2018)

Angiogenesis—An Emerging Role in Organ Fibrosis
por: Wang, Dan, et al.
Publicado: (2023)

Hydrogel scaffolds in bone regeneration: Their promising roles in angiogenesis
por: Liu, Jun, et al.
Publicado: (2023)

Exotic decay modes of $^{248}Cm$ and $^{252}Cf$ nuclei
por: Pyatkov, Yu V
Publicado: (1998)

S248. RELATION BETWEEN CHILDHOOD TRAUMA AND PSYCHOTIC SYMPTOMS IN SCHIZOPHRENIA
por: Larnaout, Amine, et al.
Publicado: (2018)

CD248: A therapeutic target in cancer and fibrotic diseases
por: Teicher, Beverly A.
Publicado: (2019)

Esophageal feeding tube placement and the associated complications in 248 cats
por: Breheny, Craig R., et al.
Publicado: (2019)

Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies
por: Yang, Fa, et al.
Publicado: (2016)

Identification of a Hypoxia-Angiogenesis lncRNA Signature Participating in Immunosuppression in Gastric Cancer
por: Wang, Zicheng, et al.
Publicado: (2022)

Low Concentration of S100A8/9 Promotes Angiogenesis-Related Activity of Vascular Endothelial Cells: Bridges among Inflammation, Angiogenesis, and Tumorigenesis?
por: Li, Changyou, et al.
Publicado: (2012)

High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway
por: Zhang, Jingliang, et al.
Publicado: (2018)

P53 codon 11, 72, and 248 gene polymorphisms in endometriosis
por: Hsieh, Yao-Yuan, et al.
Publicado: (2006)

CD248 facilitates tumor growth via its cytoplasmic domain
por: Maia, Margarida, et al.
Publicado: (2011)

CD248 as a novel therapeutic target in pulmonary arterial hypertension
por: Xu, Tao, et al.
Publicado: (2020)

SAT-248 Cushing’s Disease with Two ACTH-Producing Pituitary Tumors
por: Mathai, Christine, et al.
Publicado: (2020)

Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients
por: El Zomor, Hossam, et al.
Publicado: (2020)

Outcomes of Implant Removal and Capsulectomy for Breast Implant Illness in 248 Patients
por: Katsnelson, Jacob Y., et al.
Publicado: (2021)

248. Outcomes of Patients with Prosthetic Septic Arthritis with Debridement and Implant Retention
por: Mahatanan, Rattanaporn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9u0d3q1g5liuit3ibenf2pqcg7